Theratechnologies Inc. (THTX) Misses Q4 EPS by 1c; Offers Guidance

Theratechnologies Inc. (NASDAQ: THTX) reported Q4 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $21.42 million versus the consensus estimate of $20.75 million.

GUIDANCE:

Theratechnologies Inc. sees FY2023 revenue of $90-95 million, versus the consensus of $93.071 million.

For earnings history and earnings-related data on Theratechnologies Inc. (THTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c